Role of loco-regional treatments for patients with breast cancer liver metastases;Ruolo dei trattamenti loco-regionali nelle pazienti con metastasi epatiche da carcinoma della mammella

Recenti Progressi in Medicina

Volumn 100, Issue 9, 2009, Pages 424-433

  Raimondi, Cristina ^a   Danova, Marco ^b   Chatzileontiadou, Sofia ^b   Palmeri, Laura ^a   Vercelli, Alessandro ^b   Palmeri, Sergio ^a  

^a Policlinico P Giaccone   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Hepatic resection; Liver metastases from breast cancer; Loco regional treatment; Radio frequency ablation

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; BEVACIZUMAB; TRASTUZUMAB;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; HUMAN; LIVER METASTASIS; LIVER RESECTION; MORBIDITY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL RISK; TREATMENT OUTCOME;

BREAST NEOPLASMS; CATHETER ABLATION; DECISION TREES; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS;

EID: 70350164603     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Silva Orlando E, Zurrida S, eds. Breast cancer. A practical guide. Third edition New York: Elsevier Saunders 2005.
2. Mack M, Straub R, Eichler K, Söllner O, Lehnert T, Vogl TJ. Breast cancer metastases in liver: laser-induced interstitial thermotherapy- local tumor control rate and survival data. Radiology 2004; 233: 400-409 (Pubitemid 39423798)
3. Molino A, Pavarana M, Guglielmi A: Il ruolo dei trattamenti loco-regionali nella malattia metastatica. Supplemento a International Trends in Oncology 2005; 9: 83-86
4. Maksan SM, Lehnert T, Bastert, Herfarth C. Curative liver resection for metastatic breast cancer. Eur J of Surg Oncology 2000; 26: 209-212 (Pubitemid 30319223)
5. Bathe OF, Kaklamanos IG, Moffat FL, Boggs J, Franceschi D, Livingstone AS. Metastasectomy as a cytoreductive strategy for treatment of isolated pulmonary and hepatic metastases from breast cancer. Surg Oncol 1999; 8: 35-42.
6. Selzner M, Morse MA, Vredenburgh JJ, Meyers WC, Clavien PA. Liver metastases from breast cancer: long-term survival after curative resection. Surgery 2000; 127: 383-389 (Pubitemid 30225989)
7. Kuvshinoff B, Fong Y. Surgical therapy of liver metastases. Semin Oncol 2007; 34: 177-185
8. Singletary SE, Walsh G, Vauthey JN, Curley S, Sawaya R, Weber KL, et al. A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 2003; 8: 241-251
9. Sahani DV, Kalva SP. Imaging the liver. Oncologist 2004; 9: 385-397
10. Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guinebretiere JM, Spielmann M, et al. An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 2003; 185: 158-164 (Pubitemid 36143907)
11. Pocard M, Pouillart P, Asselain B, Falcou MC, Salmon RJ. Hepatic resection for breast cancer metastases: results and prognosis (65 cases). Ann Chir 2001; 126: 413-420
12. Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, et al. Is liver resection justified for patients with hepatic metastases from breast cancer? Annals of Surgery 2006; 244: 897-908.
13. Adam R, Salmon R, Elias D, et al. Breast cancer liver metastases: What way be the role of surgery combined with chemotherapy? Journal of Clinical Oncol 2007; 41: 1039.
14. Sakamoto Y, Yamamoto J, Yoshimoto M, Kasumi F, Kosuge T, Kokudo N, et al. Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients. World J Surg 2005; 29: 524-527 (Pubitemid 41125381)
15. Thelen A, Benckert C, Jonas S, Lopez-Hänninen E, Sehouli J, Neumann U, et al. Liver resection for metastases from breast cancer. J Surg Oncol 2008; 97: 25-29
16. Er O, Frye DK, Kau SW, Broglio K, Valero V, Hortobagyi GN, et al. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy. Cancer J 2008; 14: 62-68
17. Raab R, Nussbaum KT, Behrend M, Weimann A. Liver metastases of breast cancer: results of liver resection. Anticancer Res 1998; 18: 2231-2234 (Pubitemid 28386496)
18. Raab R, Nussbaum KT, Werner U, Pichlmayr R. Liver metastases in breast carcinoma. Results of partial liver resection. Chirurg 1996; 67: 234-237
19. Yoshimoto M, Tada T, Saito M, Takahashi K, Uchida Y, Kasumi F. Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat 2000; 59: 177-184 (Pubitemid 30216141)
20. Pocard M, Falcou MC, Salmon RJ. On the prognosis criteria for hepatic resection in cases of breast metastases. Surgery 2001; 129: 651-652 (Pubitemid 32374999)
21. Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J. Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat 1999; 56: 67-78. (Pubitemid 29435816)
22. Clark GM, Sledge GW Jr, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1.015 breast cancer patients. J Clin Oncol 1987; 5: 55-61. (Pubitemid 17007856)
23. Vlastos G, Smith DL, Singletary SE, Mirza NQ, Tuttle TM, Popat RJ, et al. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 2004; 11: 869-874
24. Schneebaum S, Walker MJ, Young D, Farrar WV, Minton JP. The regional treatment of liver metastases from breast cancer. J Surg Oncol 1994; 55: 26-32. (Pubitemid 24048386)
25. Bleicher RJ, Allegra DP, Nora DT, Wood TF, Foshaq LJ, Bilchik AJ. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann of Surg Oncol 2002; 10: 52-58
26. Livraghi T, Goldberg N, Solbiati L, Meloni F, Ierace T, Gazelle GS. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 2001; 220: 145-149 (Pubitemid 32577975)
27. Pereira PL. Actual role of radiofrequency ablation of liver metastases. Eur Radiol 2007; 17: 2062-2070 (Pubitemid 47097464)
28. Scaife CL, Curley SA. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignances. Surg Oncol Clin N Am 2003; 12: 243-255
29. Lencioni R, Goletti O, Armillotta N. Radio-frequency thermal ablation of liver metastases with cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998; 8: 1205-1211 (Pubitemid 128662778)
30. Rossi S, Buscarini E, Garbagnati F, Di Stasi M, Quaretti P, Rago M, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998; 170: 1015-1022 (Pubitemid 28172891)
31. Solbiati G, Ierace T, Goldberg SN. Hepatic metastases: percutaneous radio-frequency ablation with cooled-yip electrode. Radiology 1997; 205: 367-373
32. van Duijnhoven FH, Jansen MC, Junggeburt JM, van Hillegersberg R, Rijken AM, van Coevorden F, et al. Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol 2006; 13: 651-658
33. Kuvshinoff BW, Ota DM: Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 2002; 132: 605-611
34. Kornprat P, Jarnagin WR, Gonen M, De Matteo RP, Fong Y, Blumgart LH, et al. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 2007; 14: 1151-1160
35. Garrean S, Hering J, Scott Helton W, Espat NJ. A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors. Am J Surg 2007; 194: 79-88. (Pubitemid 46874356)
36. Biasco G, Derenzini E, Grazi G, Ercolani G, RavaioIi M, Pantaleo MA, et al. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev 2006; 32: 214-218
37. Molica S, De Vita VT Jr, Hellman S. Targeted therapies: anticorpi monoclonali. International Trends in Oncology 2005; 3: 68-73,
38. Gasparini G, Longo R, Torino F, Morabito A. Therapy of breast cancer with molecular targeting agents. Ann Oncol 2005; 16: 28-36. (Pubitemid 43084943)
39. O' Shaughnessy J. Extending survival with chemotherapy in metastic breast cancer. Oncol 2005; 10: 20-29
40. Bruzzi P, Del Mastro L, Sormani MP, Bastholt L, Danova M, Focan C, et al. Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer. J Clin Oncol 2005; 23: 5117-5125 (Pubitemid 46224020)
41. Chung CT, Carlson RW. Goals and objectives in the management of metastatic breast cancer. Oncologist 2003; 8: 14-20.
42. Fumoleau P. Treatment of patients with liver metastases. Anti-Cancer Drugs 1996; 7 (suppl 2): 21-23 (Pubitemid 26275618)
43. Atalay G, Biganzoli L, Renard F, Paridaens R, Cufer T, Coleman R, et al. Clinical outcome of breast cancer patients with liver metastases in the anthracycline-taxane era. Breast Cancer Res Treat 2002; 76 (suppl 1): S47.
44. Lernite E, Marzano E, Chéreau E, Ronzier R, Pessaux P. Surgical resection of liver metastases from breast cancer. Surg Oncol 2009; July 8 [Epub ahead of print].
45. Diamond JR, Finlayson CA, Borges VF. Hepatic complication of breast cancer. Lancet Oncol 2009; 10: 615-621
46. Vogl TJ, Naquib NN, Nour-Eldin, Eichler K, Zangos S, Gruber-Rouh T. Transarterial chemoembolization (TACE) with mitomycin C and pemcitabine for liver metastases in breast cancer. Eur Radiol 2009; August 6 [Epub ahead of print].